Conferences Genesis Drug Discovery & Development (GD3) is attending in 2027
Genesis Drug Discovery & Development (GD3) is listed at 2 conferences on Tnuki's calendar in 2027: SOT 2027 (exhibiting) and AACR 2027 (exhibiting). Genesis Drug Discovery & Development (GD3) is a contract research organization providing drug discovery, preclinical development, and toxicology services to pharmaceutical and biotechnology companies. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
SOT 2027 Annual Meeting & ToxExpoToxicologists & safety scientistsOfficial site |
San Antonio, TX ~4k attendees | ExhibitorAs published by Society of Toxicology Booth 1345
Attendee mix: Evenly mixed pharma, chemicals & academia; toxicologists and safety-assessment leads
|
Open the guide Search and filter attendees |
AACR Annual Meeting 2027World’s largest cancer research meetingOfficial site |
Orlando, FL ~23k attendees | ExhibitorAs published by American Association for Cancer Research Booth 2068
Attendee mix: Mostly academic, strong biopharma presence; cancer research PIs, trainees, oncologists, translational and oncology R&D
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Genesis Drug Discovery & Development (GD3)’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Genesis Drug Discovery & Development (GD3)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!